Utero opioid exposure increases risk of neonatal opioid withdrawal syndrome
Investigators found that opioid use during pregnancy increases the relative risk of neonatal opioid withdrawal syndrome in newborns.
IFX biosimilar reduces the cost of treating inflammatory bowel diseases
While further studies are needed to confirm the long-term effects, recent studies have shown the infliximab biosimilar to be a safe, effective, and cost reducing treatment for inflammatory bowel diseases.
Ibrutinib approved for pediatric chronic graft versus host disease
Ibrutinib (IMBRUVICA; AbbVie) was approved by the US Food and Drug Administration for use in pediatric patients with chronic graft versus host disease.
AAP addresses sexual and gender-based harassment in pediatric spaces
The American Academy of Pediatrics has released a policy statement addressing sexual and gender-based harassment in pediatric workplaces and classrooms, and advises physicians on how to tackle these issues.
Atomoxetine reduces anxiety in children with ADHD
A recent review suggests that atomoxetine can reduce symptoms of anxiety in children and adolescents with ADHD.
Triptan use during pregnancy does not increase ADHD risk
A recent study showed no correlation between prenatal exposure to triptans and diagnosis or symptoms of ADHD in children.
HHS announces actions to improve child mental health care
The US Department of Health and Human Services has announced 3 key actions to strengthen health care for US children, including addressing the mental health crisis in youths.
Gestational diabetes mellitus rate increased from 2016 to 2020
Data from the US Department of Health and Human Services has shown an increase in GDM rate from 2016 to 2020, with a greater increase observed from 2019 to 2020.
Potential dupilumab use in children aged 1 to 11 with eosinophilic esophagitis
A phase 3 trial of dupilumab (Dupixent; Sanofi and Regeneron) has shown positive results for use in children aged 1 to 11 years afflicted with eosinophilic esophagitis.
FDA expands approval of Mirena for up to 8 years
After a recent FDA approval, Mirena can be used to prevent pregnancy for up to 8 years.
Updated information on chronic granulomatous disease
Research by Ben Katz, MD, and other investigators has brought new insight on chronic granulomatous disease to light.
Hummingbird TTS ear tube system expanded for use in young children
The Hummingbird TTS will make ear procedures much less complicated and expensive, and it is now cleared for children aged 6 months and above.
Individualized management reduces preterm birth
A recent study showed reductions in preterm birth and admissions in neonatal intensive care units after individualized management in cases of preterm premature rupture of membranes.
Behavioral sleep stage classification methods need further development
Behavioral sleep stage classification methods were found to share categories among one another but have lacking evidence of validity and reliability.
FDA approves Zynteglo for patients with beta-thalassemia needing regular blood transfusions
Following its FDA approval, Zynteglo will be used to treat beta-thalassemia in adults and pediatric patients who require a regular red blood cell transfusion.
New atopic dermatitis treatments in development
Children with atopic dermatitis will soon have more options for treatment, as clinical trials show promising results.
AAP outlines safety tips for children returning to school
The American Academy of Pediatrics has outlined safety tips to keep children physically and emotionally healthy as they return to school this season.
AAP: Text message reminders raise flu vaccination rates
In a recent study, researchers found that text message reminders led to increased influenza vaccination rates, along with many receiving the vaccine sooner.
Atopic dermatitis negatively impacts family life
A recent survey showed correlation between the severity of atopic dermatitis and the negative impacts on family life.
AAP: Helmets reduce risk of brain injury
The American Academy of Pediatrics reminded parents of the importance of helmet use and encouraged helmet use discussion with their children.
Pediatric psoriasis treatment challenges
Investigators have found that there are limited options for treating pediatric psoriasis.
FDA approves Xofluza for treatment of influenza in children 5 years and older
Xofluza is now the first single-dose oral medication for influenza approved for children aged less than 12 years.
Antimicrobial Stewardship Programs decrease antibiotic initiation at birth
ASP treatment lowered the presence of sepsis risk factors in preterm infants.
Low birth weight associated with attention problems in children
Investigators found that symptoms of attention-deficit/hyperactivity disorder were more often seen in children with a lower birth weight.
Possible mediators for perioperative respiratory adverse events discussed
Investigators compared the effects of midazolam, dexmedetomidine, and saline control on the appearance of perioperative respiratory adverse events in children.
Pharmacological treatments found effective against substance use disorders
Treatments for ADHD proved to be the most effective in reducing the risks of developing substance use disorders.
Less invasive surfactant administration reduces adverse outcomes in infants
A study by the German Neonatal Network associated application of less invasive surfactant administration with fewer complications and lower mortality rates.
Few pediatric devices were approved after a clinical trial involving children
Many devices approved for pediatric use were not tested in a clinical trial involving children.
Parents express low confidence in pediatric COVID-19 vaccine
Only one-fifth of parents in a recent survey indicated intentions of getting their child the vaccine within 3 months of eligibility.
Child death by gun violence increased during COVID-19 pandemic
Studies indicate that child deaths by gun violence were comparable to those by COVID-19.